enGene Holdings Inc. Common Stock

Stock Chart, Company Information, and Scan Results

$2.28(as of Nov 12, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

enGene Holdings Inc. Common Stock Company Information, Fundamentals, and Technical Indicators

Stock Price$2.28
Ticker SymbolENGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees81
CountyUSA
Market Cap$118.6M
EBIDTA-135.9M
10-Day Moving Average1.73
P/E Ratio-32.42
20-Day Moving Average1.66
Forward P/E Ratio0.00
50-Day Moving Average1.78
Earnings per Share-2.07
200-Day Moving Average3.98
Profit MarginUnknown
RSI72.40
Shares Outstanding67.0M
ATR0.14
52-Week High12.25
Volume11,849,613
52-Week Low1.40
Most Recent Support Level1.63
Book Value230.3M
Most Recent Resistance Level1.80
P/B Ratio0.69
Upper Keltner1.98
P/S RatioUnknown
Lower Keltner1.34
Debt-to-Equity Ratio0.14
Next Earnings Date12/28/2026
Cash Surplus13.8M
Next Ex-Dividend DateUnknown

enGene Therapeutics Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. The company was formerly known as enGene Holdings Inc. and changed its name to enGene Therapeutics Inc. in April 2026. enGene Therapeutics Inc. is based in Montreal, Canada.

enGene Holdings Inc. Common Stock In Our Stock Scanner

As of Nov 12, 2026
example chart graphic
Scan Name: Undervalued Blue ChipsScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Momentum StocksScan Type: Stock Indicator Scans
As of ---
example chart graphic
Scan Name: Unusual VolumeScan Type: Stock Indicator Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.